An Efficacy and Safety Study of Omacor® in Taiwanese Hypertriglyceridemic Patients

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 253 participants.

Also called NCT01725646

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 253 participants (enrolled count) (from the registry)
Sponsor
Excelsior (from the registry)
Registry
  • NCT NCT01725646
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Taiwan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01725646. Randomized; quadruple masking; primary purpose treatment. Start 2011-07 (registry gives no type); primary completion 2013-07 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
An Efficacy and Safety Study of Omacor® in Taiwanese Hypertriglyceridemic Patients
Condition
Hypertriglyceridemia
Intervention (Drug)
Omacor®
Intervention (Drug)
Placebo
Lead sponsor
Excelsior (class: industry)

Record details

Record id
cardio:ct-nct01725646
Content hash
3b3ca6e468d4e94cbd1744973f969fae52e8e2a136b762a5a90aeefddd48a23d